| Brittany Kirsten Vickers, MS, CCC-SLP | |
|
1135 2nd Ave W Ste 207, Williston, ND 58801-4175 | |
| (701) 205-6318 | |
| (866) 279-5137 |
| Full Name | Brittany Kirsten Vickers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1135 2nd Ave W Ste 207, Williston, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437318268 | NPI | - | NPPES |
| 1455937 | Medicaid | ND | |
| 2328 | Other | ND | ND STATE SLP LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2328 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Kirsten Vickers, MS, CCC-SLP 205 11th St E, Williston, ND 58801-5445 Ph: (701) 205-6318 | Brittany Kirsten Vickers, MS, CCC-SLP 1135 2nd Ave W Ste 207, Williston, ND 58801-4175 Ph: (701) 205-6318 |
News Archive
InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.
Alexandria Real Estate Equities, Inc., the largest and leading REIT uniquely focused on collaborative science campuses in urban innovation clusters, announced today that Bristol-Myers Squibb, a global biopharmaceutical company, will establish a state-of-the-art research and development center at the Alexandria Center at Kendall Square (ACKS) in the heart of the Cambridge Kendall Square innovation cluster.
A common protein that protects plants from fungal infection mimics the activity of a hormone in mammals that is linked to weight loss and is believed to play a role in mitigating heart disease, obesity and diabetes, according to a team of researchers at Purdue University and several collaborating institutions.
The current study attempts to estimate the quantitative effects of specific measures, using a combination of phylogenetic and phylodynamic approaches.
Abbott announced today that it will expand its existing agreement with GlaxoSmithKline Biologicals S.A. to include the development of an additional companion diagnostic test in support of GSK's cancer immunotherapy research program.
› Verified 6 days ago
Brenda Kay Schafer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Dakota Pkwy, Williston, ND 58801 Phone: 701-572-6757 | |
Hannah R Rasmussen, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1910 23rd St W, Williston, ND 58801 Phone: 952-406-2572 | |
Cierra M Stevens, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1905 14th St W, Williston, ND 58801 Phone: 701-651-6437 Fax: 701-516-8462 | |
Lynn R Haugeberg, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Dakota Pkwy, Williston, ND 58801 Phone: 701-572-6757 Fax: 701-755-3532 | |
Tessa M Neether, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 221 University Ave Ste 203, Williston, ND 58801 Phone: 701-580-8788 | |
Debra J Kellogg, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Dakota Pkwy, Williston, ND 58801 Phone: 701-572-6757 Fax: 701-744-3532 | |
April Wallner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Dakota Pkwy, Williston, ND 58801 Phone: 701-572-6757 |